Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
SELECTA BIOSCIENCES INC (SELB)
Sector: Healthcare; Industry: Biotechnology

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Selecta Biosciences, Inc. has license and collaboration agreements with Spark Therapeutics, Massachusetts Institute of Technology, Shenyang Sunshine Pharmaceutical Co., Ltd., and BIND Therapeutics, Inc.; and a strategic partnership with Asklepios BioPharmaceutical, Inc. for the development, manufacture, and commercialization of targeted therapeutics for adeno-associated virus gene therapies in the areas of high medical need. The company was founded in 2007 and is headquartered in Watertown, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-10-09 SPRINGER TIMOTHY A 10%-Owner, Director Buy 276,703 $2.00 $552,465 No
2020-10-08 SPRINGER TIMOTHY A 10%-Owner, Director Buy 3,185,394 $1.71 $5,445,213 No
2020-10-06 BARABE TIMOTHY C Director Buy 50,000 $1.68 $83,985 No
2020-09-02 Brunn Carsten President and CEO Sell 3,364 $2.39 $8,035 Yes
2020-06-02 Brunn Carsten President and CEO Sell 3,253 $3.86 $12,557 Yes
2020-03-17 BARABE TIMOTHY C Director Buy 5,000 $2.00 $10,000 No
2020-03-03 Brunn Carsten President and CEO Sell 3,374 $3.86 $13,011 Yes
2019-12-02 Brunn Carsten President and CEO Sell 14,272 $1.53 $21,809 Yes
2019-08-14 SPRINGER TIMOTHY A 10%-Owner, Director Buy 10,000 $1.74 $17,415 No
2019-08-13 BARABE TIMOTHY C Director Buy 10,000 $1.72 $17,200 No
2019-01-25 Farokhzad Omid Director Buy 83,333 $1.50 $125,000 No
2019-01-25 SPRINGER TIMOTHY A Director Buy 4,071,418 $1.51 $6,142,905 No
2019-01-25 Nashat Amir Director Buy 1,166,666 $1.50 $1,749,999 No
2017-11-17 Sands Earl Chief Medical Officer Buy 7,500 $10.26 $76,966 No
2017-11-14 SPRINGER TIMOTHY A Director Buy 57,598 $9.27 $534,095 No
2017-11-14 Abraham David GC, CCO & Corporate Secretary Buy 5,405 $9.25 $49,996 No
2017-11-13 CAUTREELS WERNER President and CEO Buy 20,000 $9.31 $186,250 No
2017-11-10 SPRINGER TIMOTHY A Director Buy 53,338 $9.19 $490,437 No
2017-11-10 BARABE TIMOTHY C Director Buy 5,000 $9.37 $46,840 No
2017-09-26 Nashat Amir Director Sell 70,226 $18.91 $1,328,079 No
2017-09-25 Nashat Amir Director Sell 79,211 $19.13 $1,515,664 No
2017-09-20 Siewers David CFO and Treasurer Sell 16,424 $20.00 $328,480 Yes
2017-09-21 Nashat Amir Director Sell 147,187 $19.91 $2,930,215 No
2017-06-15 Johnston Lloyd P. COO and SVP, R&D Sell 10,512 $17.04 $179,141 Yes
2017-07-03 Johnston Lloyd P. COO and SVP, R*D Sell 5,959 $19.10 $113,806 Yes
2017-06-30 Siewers David Chief Financial Officer Sell 7,420 $20.00 $148,405 Yes
2017-06-29 Siewers David Chief Financial Officer Sell 9,652 $20.00 $193,042 Yes
2017-06-27 SPRINGER TIMOTHY A Director Buy 338,791 $17.71 $5,999,989 Yes
2017-06-27 Keller Peter Chief Business Officer Sell 4,595 $19.30 $88,681 Yes
2017-06-26 Siewers David Chief Financial Officer Sell 6,886 $20.00 $137,720 No

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.